Acute Porphyria Drug Database

Monograph

C07AA07 - Sotalol
Not porphyrinogenic
NP

Rationale
Beta-blocker, not metabolised. Occasional clinical observation of tolerance. Two references state non-porphyrinogenicity.
Chemical description
Watersoluble beta-receptor blocking substance. Excreted unchanged in urine. Thunell, patient reports (n=3 ): tolerated. South African list: use. French list: authorized. EPI: safe (betablockers)
IPNet drug reports
Uneventful use reported in 6 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes C07A / C07AA or go back.
Tradenames
This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.


Sotalol Sotalex · Sotalol Sotalol · Sotapor Rytmobeta · Sotalex · Sotalolo Darob · Sotagamma · Sotalol Beta-Cardone · Sotacor · Sotalol Sotalol Sotalol Biosotal · Sotahexal · Sotalol Sotalex Sotalol Sotacor · Sotalol Sotagamma Darob
 
© NAPOS 2025
An unhandled error has occurred. Reload 🗙